| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 107 |
| 1 | DEXAMETHASONE 1.5 MG | 105 |
| 2 | BORTEZOMIB | 73 |
| 3 | METHOTREXATE SODIUM | 69 |
| 4 | MIRVETUXIMAB SORAVTANSINE | 60 |
| 5 | METHOTREXATE | 58 |
| 6 | POMALIDOMIDE | 55 |
| 7 | ADALIMUMAB | 52 |
| 8 | DICLOFENAC SODIUM | 45 |
| 9 | DICLOFENAC | 42 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROPARACAINE HYDROCHLORIDE | 32 | 0.0599 |
| 1 | SODIUM HYALURONATE | 38 | 0.0462 |
| 2 | CYCLOPENTOLATE HYDROCHLORIDE | 26 | 0.0395 |
| 3 | MIRVETUXIMAB SORAVTANSINE | 60 | 0.0331 |
| 4 | FLUOROMETHOLONE ACETATE | 5 | 0.0187 |
| 5 | BALANCED SALT SOLUTION | 24 | 0.0186 |
| 6 | OMIDENEPAG ISOPROPYL | 1 | 0.0152 |
| 7 | POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE | 2 | 0.0123 |
| 8 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 9 | 0.0079 |
| 9 | IBERDOMIDE | 1 | 0.0067 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 14 | 0.0027 |
| 1 | Plasma Volume Expander [EPC] | 7 | 0.0023 |
| 2 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 5 | 0.0009 |
| 4 | Quinolone Antimicrobial [EPC] | 8 | 0.0008 |
| 5 | Proteasome Inhibitor [EPC] | 86 | 0.0008 |
| 6 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 6 | 0.0006 |
| 7 | Nuclear Export Inhibitor [EPC] | 5 | 0.0006 |
| 8 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 9 | Carbonic Anhydrase Inhibitor [EPC] | 8 | 0.0004 |